Literature DB >> 28847514

Omega-3 polyunsaturated fatty acids ameliorate ethanol-induced adipose hyperlipolysis: A mechanism for hepatoprotective effect against alcoholic liver disease.

Meng Wang1, Xiaojiao Zhang1, Li-Juan Ma1, Rui-Bing Feng1, Chunyan Yan2, Huanxing Su1, Chengwei He1, Jing X Kang3, Baolin Liu4, Jian-Bo Wan5.   

Abstract

Alcohol exposure induces adipose hyperlipolysis and causes excess fatty acid influx into the liver, leading to alcoholic steatosis. The impacts of omega-3 polyunsaturated fatty acids (n-3 PUFA) on ethanol-induced fatty liver are well documented. However, the role of n-3 PUFA in ethanol-induced adipose lipolysis has not been sufficiently addressed. In this study, the fat-1 transgenic mice that synthesizes endogenous n-3 from n-6 PUFA and their wild type littermates with an exogenous n-3 PUFA enriched diet were subjected to a chronic ethanol feeding plus a single binge as model to induce liver injury with adipose lipolysis. Additionally, the differentiated adipocytes from 3T3-L1 cells were treated with docosahexaenoic acid or eicosapentaenoic acid for mechanism studies. Our results demonstrated that endogenous and exogenous n-3 PUFA enrichment ameliorates ethanol-stimulated adipose lipolysis by increasing PDE3B activity and reducing cAMP accumulation in adipocyte, which was associated with activation of GPR120 and regulation of Ca2+/CaMKKβ/AMPK signaling, resultantly blocking fatty acid trafficking from adipose tissue to the liver, which contributing to ameliorating ethanol-induced adipose dysfunction and liver injury. Our findings identify that endogenous and exogenous n-3 PUFA enrichment ameliorated alcoholic liver injury by activation of GPR120 to suppress ethanol-stimulated adipose lipolysis, which provides the new insight to the hepatoprotective effect of n-3 PUFA against alcoholic liver disease.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adipose lipolysis; Alcoholic liver disease; CaMKKβ; GPR120; Omega-3 polyunsaturated fatty acids

Mesh:

Substances:

Year:  2017        PMID: 28847514     DOI: 10.1016/j.bbadis.2017.08.026

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  16 in total

1.  Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver.

Authors:  Thiyagarajan Gopal; Narendra Kumar; Curtis Perriotte-Olson; Carol A Casey; Terrence M Donohue; Edward N Harris; Geoffrey Talmon; Alexander V Kabanov; Viswanathan Saraswathi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-13       Impact factor: 4.052

Review 2.  A review of the role of ethanol-induced adipose tissue dysfunction in alcohol-associated liver disease.

Authors:  Thiyagarajan Gopal; Weilun Ai; Carol A Casey; Terrence M Donohue; Viswanathan Saraswathi
Journal:  Alcohol Clin Exp Res       Date:  2021-09-23       Impact factor: 3.928

3.  The Role of Omega-3 Polyunsaturated Fatty Acids from Different Sources in Bone Development.

Authors:  Reut Rozner; Janna Vernikov; Shelley Griess-Fishheimer; Tamar Travinsky; Svetlana Penn; Betty Schwartz; Ronit Mesilati-Stahy; Nurit Argov-Argaman; Ron Shahar; Efrat Monsonego-Ornan
Journal:  Nutrients       Date:  2020-11-13       Impact factor: 5.717

4.  Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars.

Authors:  Panu K Luukkonen; Sanja Sädevirta; You Zhou; Brandon Kayser; Ashfaq Ali; Linda Ahonen; Susanna Lallukka; Véronique Pelloux; Melania Gaggini; Ching Jian; Antti Hakkarainen; Nina Lundbom; Helena Gylling; Anne Salonen; Matej Orešič; Tuulia Hyötyläinen; Marju Orho-Melander; Aila Rissanen; Amalia Gastaldelli; Karine Clément; Leanne Hodson; Hannele Yki-Järvinen
Journal:  Diabetes Care       Date:  2018-05-29       Impact factor: 19.112

5.  Antibacterial and Anti-Biofilm Activity of Omega-3 Polyunsaturated Fatty Acids against Periprosthetic Joint Infections-Isolated Multi-Drug Resistant Strains.

Authors:  Débora C Coraça-Huber; Stephan Steixner; Alexander Wurm; Michael Nogler
Journal:  Biomedicines       Date:  2021-03-26

6.  Red yeast rice ameliorates non-alcoholic fatty liver disease through inhibiting lipid synthesis and NF-κB/NLRP3 inflammasome-mediated hepatic inflammation in mice.

Authors:  Jian Zou; Chunyan Yan; Jian-Bo Wan
Journal:  Chin Med       Date:  2022-01-25       Impact factor: 5.455

7.  Decreased ω-6:ω-3 PUFA ratio attenuates ethanol-induced alterations in intestinal homeostasis, microbiota, and liver injury.

Authors:  Dennis R Warner; Jeffrey B Warner; Josiah E Hardesty; Ying L Song; Taylor N King; Jing X Kang; Chih-Yu Chen; Shanfu Xie; Fang Yuan; Md Aminul Islam Prodhan; Xipeng Ma; Xiang Zhang; Eric C Rouchka; Krishna Rao Maddipati; Joan Whitlock; Eric C Li; Gary P Wang; Craig J McClain; Irina A Kirpich
Journal:  J Lipid Res       Date:  2019-10-04       Impact factor: 5.922

Review 8.  Malnutrition and Alcohol-Associated Hepatitis.

Authors:  Craig J McClain; Cristian D Rios; Sally Condon; Luis S Marsano
Journal:  Clin Liver Dis       Date:  2021-05-26       Impact factor: 6.126

9.  BabaoDan attenuates high-fat diet-induced non-alcoholic fatty liver disease via activation of AMPK signaling.

Authors:  Dandan Sheng; Shanmin Zhao; Lu Gao; Huifei Zheng; Wenting Liu; Jing Hou; Yuxiang Jin; Fei Ye; Qiudong Zhao; Rong Li; Naping Zhao; Li Zhang; Zhipeng Han; Lixin Wei
Journal:  Cell Biosci       Date:  2019-09-18       Impact factor: 9.584

10.  Oxidation of fish oil exacerbates alcoholic liver disease by enhancing intestinal dysbiosis in mice.

Authors:  Ruibing Feng; Li-Juan Ma; Meng Wang; Conghui Liu; Rujie Yang; Huanxing Su; Yan Yang; Jian-Bo Wan
Journal:  Commun Biol       Date:  2020-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.